abivax.com
#529,256
Global Rankeez rank — last updated 01 Nov 2026
Better than 99.5% of the 100,511,422 domains we track
Best rank recorded
#507,296
2026-10
Worst rank recorded
#719,282
2026-07
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how abivax.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #869,521 |
| Majestic Million (ranked by referring subnets) | #376,081 |
| CommonCrawl (hyperlink graph) | #8,895,468 |
See how these sources are combined and cross-validated →
Ranking history
abivax.com's rank across 4 monthly snapshots. ▲ improved by 190,026 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #719,282 |
| 2026-08 | #712,079 |
| 2026-10 | #507,296 |
| 2026-11 | #529,256 |
JSON API
{
"abivax.com": 529256,
"history": {
"2026-07": 719282,
"2026-08": 712079,
"2026-10": 507296,
"2026-11": 529256
}
}
GET https://rankeez.com/api/abivax.com.json · see API docs →
More about abivax.com
abivax.com — page content & similar sites →
Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. Vie
abivax.com — full site profile →
WHOIS, tech stack and extended traffic history for abivax.com.